Information Library
Results for: Consulting - Product Development & Commercialization - Regulatory & Quality
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
Consulting – Breakthrough Thinking Built on Experience
Brochure — November 23, 2010
Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. -
Safety Strategy & Optimization
Brochure — September 14, 2010
Learn how to enable your safety group to become a value-added contributor throughout the product lifecycle. -
Managing Pharmacovigilance as a Business
White Paper — July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment
Presentation — June 30, 2010
-
Regulations for Clinical Studies in Pediatric Patients in the European Union
White Paper — March 10, 2010
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric -
PharmAsia News Article Reprint
Media Coverage — March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News. -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
Robert A. Pearlstein
Hear from the Experts — March 25, 2009
Bob is a co-founder of Eidetics, and has over two decades of experience assessing commercial opportunities and creating product strategies for biopharma and medical device clients worldwide. -
George A. Mabry
Hear from the Experts — March 25, 2009
George joined Eidetics in 1989 after a successful career in consumer and industrial products marketing and strategic planning. He previously held product management positions at General Foods and senior marketing management positions at Teradyne.
